Provided by Tiger Trade Technology Pte. Ltd.

Ensysce Biosciences Inc.

0.4869
-0.0290-5.62%
Post-market: 0.49000.0031+0.64%19:53 EDT
Volume:562.75K
Turnover:281.55K
Market Cap:9.47M
PE:-0.18
High:0.5230
Open:0.5200
Low:0.4769
Close:0.5159
52wk High:2.75
52wk Low:0.2300
Shares:19.46M
Float Shares:18.38M
Volume Ratio:0.69
T/O Rate:3.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7523
EPS(LYR):-3.9790
ROE:-1295.09%
ROA:-185.51%
PB:-12.12
PE(LYR):-0.12

Loading ...

Jan 19, 2023

Major Issues Report

8-K - Current report
Jan 13, 2023

Correspondence

CORRESP [Cover] - Correspondence
Jan 13, 2023

Major Issues Report

8-K - Current report
Dec 27, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 16, 2022

Major Issues Report

8-K - Current report
Dec 16, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 08, 2022

Major Issues Report

8-K - Current report
Dec 06, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 06, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 05, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Dec 01, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Nov 18, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Nov 17, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Nov 16, 2022

Correspondence

CORRESP [Cover] - Correspondence
Nov 14, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 28, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Oct 27, 2022

Major Issues Report

8-K - Current report
Sep 20, 2022

Major Issues Report

8-K - Current report
Sep 16, 2022

Major Issues Report

8-K - Current report